196 related articles for article (PubMed ID: 24924423)
1. Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.
Armstrong MM; Diaz G; Kenyon V; Holman TR
Bioorg Med Chem; 2014 Aug; 22(15):4293-7. PubMed ID: 24924423
[TBL] [Abstract][Full Text] [Related]
2.
Tsai WC; Kalyanaraman C; Yamaguchi A; Holinstat M; Jacobson MP; Holman TR
Biochemistry; 2021 Jun; 60(22):1741-1754. PubMed ID: 34029049
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Investigations of Acyl-CoA Derivatives against Human Lipoxygenase Isozymes.
Tran M; Yang K; Glukhova A; Holinstat M; Holman T
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446119
[TBL] [Abstract][Full Text] [Related]
4. A potent and selective inhibitor targeting human and murine 12/15-LOX.
Armstrong MM; Freedman CJ; Jung JE; Zheng Y; Kalyanaraman C; Jacobson MP; Simeonov A; Maloney DJ; van Leyen K; Jadhav A; Holman TR
Bioorg Med Chem; 2016 Mar; 24(6):1183-90. PubMed ID: 26899595
[TBL] [Abstract][Full Text] [Related]
5. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
Powell WS; Rokach J
Prog Lipid Res; 2013 Oct; 52(4):651-65. PubMed ID: 24056189
[TBL] [Abstract][Full Text] [Related]
6. 15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation.
Wei C; Zhu P; Shah SJ; Blair IA
Mol Pharmacol; 2009 Sep; 76(3):516-25. PubMed ID: 19535459
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 5- and 6-fluoro derivatives of arachidonic acid and 5,8,14-eicosatrienoic acid as substrates and inhibitors of 5-lipoxygenase.
Navé JF; Jacobi D; Gaget C; Dulery B; Ducep JB
Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):549-55. PubMed ID: 1898346
[TBL] [Abstract][Full Text] [Related]
8. Investigating the catalytic efficiency of C22-Fatty acids with LOX human isozymes and the platelet response of the C22-oxylipin products.
Tran M; Stanger L; Narendra S; Holinstat M; Holman TR
Arch Biochem Biophys; 2023 Oct; 747():109742. PubMed ID: 37696384
[TBL] [Abstract][Full Text] [Related]
9. Reevaluation of a Bicyclic Pyrazoline as a Selective 15-Lipoxygenase V-Type Activator Possessing Fatty Acid Specificity.
van Hoorebeke C; Yang K; Mussetter SJ; Koch G; Rutz N; Lokey RS; Crews P; Holman TR
ACS Omega; 2022 Nov; 7(47):43169-43179. PubMed ID: 36467910
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of the Maresin Intermediate, 13S,14S-Epoxy-DHA, by Human 15-Lipoxygenase and 12-Lipoxygenase and Its Regulation through Negative Allosteric Modulators.
Freedman C; Tran A; Tourdot BE; Kalyanaraman C; Perry S; Holinstat M; Jacobson MP; Holman TR
Biochemistry; 2020 May; 59(19):1832-1844. PubMed ID: 32324389
[TBL] [Abstract][Full Text] [Related]
11. Kinetic and structural investigations of novel inhibitors of human epithelial 15-lipoxygenase-2.
Tsai WC; Gilbert NC; Ohler A; Armstrong M; Perry S; Kalyanaraman C; Yasgar A; Rai G; Simeonov A; Jadhav A; Standley M; Lee HW; Crews P; Iavarone AT; Jacobson MP; Neau DB; Offenbacher AR; Newcomer M; Holman TR
Bioorg Med Chem; 2021 Sep; 46():116349. PubMed ID: 34500187
[TBL] [Abstract][Full Text] [Related]
12. Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.
Armstrong M; van Hoorebeke C; Horn T; Deschamps J; Freedman JC; Kalyanaraman C; Jacobson MP; Holman T
Bioorg Med Chem; 2016 Nov; 24(21):5380-5387. PubMed ID: 27647374
[TBL] [Abstract][Full Text] [Related]
13. Role of Human 15-Lipoxygenase-2 in the Biosynthesis of the Lipoxin Intermediate, 5S,15S-diHpETE, Implicated with the Altered Positional Specificity of Human 15-Lipoxygenase-1.
Perry SC; Horn T; Tourdot BE; Yamaguchi A; Kalyanaraman C; Conrad WS; Akinkugbe O; Holinstat M; Jacobson MP; Holman TR
Biochemistry; 2020 Oct; 59(42):4118-4130. PubMed ID: 33048542
[TBL] [Abstract][Full Text] [Related]
14. 11-Oxoeicosatetraenoic acid is a cyclooxygenase-2/15-hydroxyprostaglandin dehydrogenase-derived antiproliferative eicosanoid.
Liu X; Zhang S; Arora JS; Snyder NW; Shah SJ; Blair IA
Chem Res Toxicol; 2011 Dec; 24(12):2227-36. PubMed ID: 21916491
[TBL] [Abstract][Full Text] [Related]
15. Development of novel peptide inhibitor of Lipoxygenase based on biochemical and BIAcore evidences.
Somvanshi RK; Singh AK; Saxena M; Mishra B; Dey S
Biochim Biophys Acta; 2008 Nov; 1784(11):1812-7. PubMed ID: 18691678
[TBL] [Abstract][Full Text] [Related]
16. 15-Lipoxygenase-1 biosynthesis of 7S,14S-diHDHA implicates 15-lipoxygenase-2 in biosynthesis of resolvin D5.
Perry SC; Kalyanaraman C; Tourdot BE; Conrad WS; Akinkugbe O; Freedman JC; Holinstat M; Jacobson MP; Holman TR
J Lipid Res; 2020 Jul; 61(7):1087-1103. PubMed ID: 32404334
[TBL] [Abstract][Full Text] [Related]
17. Pseudoperoxidase investigations of hydroperoxides and inhibitors with human lipoxygenases.
Hoobler EK; Holz C; Holman TR
Bioorg Med Chem; 2013 Jul; 21(13):3894-9. PubMed ID: 23669189
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and Cellular Characterization and Inhibitor Discovery of Pseudomonas aeruginosa 15-Lipoxygenase.
Deschamps JD; Ogunsola AF; Jameson JB; Yasgar A; Flitter BA; Freedman CJ; Melvin JA; Nguyen JV; Maloney DJ; Jadhav A; Simeonov A; Bomberger JM; Holman TR
Biochemistry; 2016 Jun; 55(23):3329-40. PubMed ID: 27226387
[TBL] [Abstract][Full Text] [Related]
19. The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity.
Nigam S; Patabhiraman S; Ciccoli R; Ishdorj G; Schwarz K; Petrucev B; Kühn H; Haeggström JZ
J Biol Chem; 2004 Jul; 279(28):29023-30. PubMed ID: 15123652
[TBL] [Abstract][Full Text] [Related]
20. Anacardic acid derived salicylates are inhibitors or activators of lipoxygenases.
Wisastra R; Ghizzoni M; Boltjes A; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2012 Aug; 20(16):5027-32. PubMed ID: 22789707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
